Author:
Bao Yong-Xia,Zhao Xiao-Dan,Deng Hong-Bin,Lu Chang-Lian,Guo Yang,Lu Xing,Deng Li-Li
Funder
a research Grant from the Postdoctoral Research Fund
a research Grant from the Natural Science Foundation of Heilongjiang Province, China
a research Grant from the PhD Research Fund
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine,General Medicine
Reference33 articles.
1. N. Watanabe, S. Niho, K. Kirita, S. Umemura, S. Matsumoto, K. Yoh, H. Ohmatsu, K. Goto, Vinorelbine and cisplatin in patients with advanced non-small cell lung cancer with interstitial pneumonia. Anticancer Res. 35, 1697–1701(2015)
2. Y. Togashi, H. Hayashi, K. Okamoto, S. Fumita, M. Terashima, M. A. de Velasco, K. Sakai, Y. Fujita, S. Tomida, K. Nakagawa, K. Nishio, Chronic nicotine exposure mediates resistance to EGFR-TKI in EGFR-mutated lung cancer via an EGFR signal. Lung Cancer 88, 16–23 (2015)
3. S. N. Bichev, D. M. Marinova, Y. G. Slavova, A. S. Savov, Epidermal growth factor receptor mutations in East European non-small cell lung cancer patients. Cell. Oncol. 38, 145–153 (2015)
4. F. Nurwidya, F. Takahashi, A. Murakami, I. Kobayashi, M. Kato, T. Shukuya, K. Tajima, N. Shimada, K. Takahashi, Acquired resistance of non-small cell lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors. Respir. Investig. 52, 82–91 (2014)
5. K. J. Gotink, M. Rovithi, R. R. de Haas, R. J. Honeywell, H. Dekker, D. Poel, K. Azijli, G. J. Peters, H. J. Broxterman, H. M. Verheul, Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib. Cell. Oncol. 38, 119–129 (2015)
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献